Helicobacter pylori infection and its role in human disease--an overview.
Helicobacter pylori (H. pylori) is probably the commonest chronic bacterial infection in humans. The bacterium colonizes the gastric epithelium and induces inflammation of the underlying mucosa. The recognition that this infection is the most important acquired factor in the pathogenesis of duodenal and gastric ulcers has transformed the management of these common disorders. Most patients with ulcers can be cured by a 1-week course of anti-H. pylori therapy, thereby removing the need for long-term acid inhibitory therapy. Eradication of the infection involves taking complex combinations of drugs and simpler eradication regimens are required. Recent epidemiological data indicate an association between H. pylori infection and the subsequent development of gastric carcinoma. If this association is established as causal, then widespread eradication of the infection may be indicated. Global eradication of H. pylori will probably rely on prophylactic or therapeutic vaccination and this approach is being actively investigated.
McColl
K E
KE
Department of Medicine and Therapeutics, Gardiner Institute, Western Infirmary, Glasgow, Scotland, UK.
D004796:Clinical Enzyme Tests; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D016480:Helicobacter pylori / Q000187:drug effects / Q000276:immunology; D006801:Humans; D010437:Peptic Ulcer / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology*; D013274:Stomach Neoplasms / Q000382:microbiology; D014510:Urease / Q000032:analysis
D014510:Urease